EDMONTON, May 23 /CNW/ - Cyplasin Biomedical Ltd today announced that its Japanese Patent application Nr Hei 9-516992 has been granted. The claims cover the characterization of a cytotoxic protein from the mucus of the sea hare Aplysia punctata and its use to treat cancer.
